AIDS TREATMENT ACTIVISTS COALITION (ATAC)
ABBOTT
ATAC DDC Liaison: Bertrand Toulouse
COMPANY INFORMATION
CONTACT INFORMATION
Community Contacts:
Eastern US: (East of Detroit)
Jim Howley
Manager, National Advocacy Relations
727-844-0795
[email protected]
Western US:
Elizabeth Valtierra
Manager, National Advocacy Relations
818-848-3544
[email protected]
PRODUCT INFORMATION
1. FDA-Approved Products:
- HIV protease inhibitors: Ritonavir (Norvir®), Lopinavir
(Kaletra®)
2. Products in Development: Discovery efforts
ongoing; none in clinical trials
Web page: Abbott HIV Infection
& AIDS http://www.rxabbott.com/hiv/hiv0044.htm;
Kaletra at http://www.kaletra.com
KEY PERSONNEL
(Working in HIV, HBV, and HCV)
- Jodi Devlin, Vice President, Antiviral Franchise
- Bill Calhoun, Director, Pharmaceutical Alliances 847-938-6411 (Business
development and activities with partner companies an key customer groups)
- Nicole Wesley, Manager, Pharmaceutical Public Affairs Telephone: 847-935-9877
- PRODUCT PLANNING AND DEVELOPMENT
- Dr. Michael Fath, Senior Manager, Global New Product Planning
- Dr. Eugene Sun, Vice President, Antiviral Clinical Development
- Dr. Dale Kempf, Senior Scientist, Antiviral Product Discovery
- MARKETING AND SALES
- Rosemarie Waleska, Director, HIV Marketing Unit
- Julie Fitzgerald, Senior Product Manager, HIV Products
- Isabelle Gaultier, Senior Manager, Antiviral/Abbott International
(Hepatitis C)
Revised September 11, 2003
Go to Main Page
E-mail the Coalition
ATAC is a national coalition of people living
with HIV/AIDS and advocates working together to end the AIDS epidemic
by improving HIV research and treatment access.